ChartRow logo
DMRA
$21.96+3.29%
as of close, Oct 27, 2026
☾ AH $21.96 +3.29%
PeersMRNALLYMDTUNHJNJTMO
Share this page

DMRA — Damora Therapeutics Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in DMRA be worth today? →
DMRA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$21.96
YTD price return
-4.56%
YTD total return
-4.56%
Next earnings
Nov 5, 2026
Market cap
1.4B
Enterprise value
815.3M
Shares outstanding
61.7M
52W low
$4.95
52W high
$38.33
From 52W high
-42.70%
From 52W low
+343.64%
52W range
51%

Volume

Rel volume
0.43×
30D volume
663.1K
30D $ vol
14M

Fundamentals

EPS (ttm)
-$10.70
Book value/share
$8.36
ROE
-50.93%
ROA
-48.35%
Current ratio
19.73

Growth (CAGR, ttm) · 10Y

Shares
+4573.11%+284.56%+127.64%n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share
+1.09%-40.80%-43.09%n/a
Price
+199.20%+18.04%-23.31%n/a
Total return
+199.20%+18.04%-23.31%n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-2.1×
Fwd P/E
-9.6×
P/B (mrq)
2.6×
Buyback yield (realized, 1y)
-4573.11%
Shareholder yield (realized, 1y)
-4573.11%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.00%

Vs own 10Y history

P/B
86th

Bar = where today’s multiple sits in DMRA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-27#

1D
+3.29%
5D
+6.24%
1M
+6.29%
3M
-25.41%
YTD
-4.56%
1Y
+198.98%
5Y
-73.46%

Financial statements

Open full DMRA financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+8.32%+0.22%
JNJJohnson & Johnson-0.92%+0.91%
ABBVAbbVie Inc.+8.34%-0.12%
UNHUnitedHealth Group Incorporated Common Stock (DE)+8.98%-0.08%
MRKMerck & Co. Inc.-4.68%+0.86%
NVSNovartis AG+7.84%+1.98%
TMOThermo Fisher Scientific Inc.+2.67%+1.19%
AMGNAmgen Inc.+8.04%+0.75%